Arena Pharmaceuticals Inc
NASDAQ:ARNA 3:59:59 PM EDT
| Market Cap (Intraday) | 4.67B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $80.13 |
| 50-Day MA | $77.64 |
| 200-Day MA | $70.32 |
Arena Pharmaceuticals, Inc. Stock, NASDAQ:ARNA
6154 Nancy Ridge Drive, San Diego, California 92121-9604
United States of America
Phone: +1.858.453.7200
Number of Employees: 320
Description
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.